per conoscere, per riflettere, per costruire reti

A survey has found that the UK is one of only four European countries out of 20 to prioritise #COVID #vaccinations for individuals with severe mental illness, despite evidence showing these patients are amongst the most at risk.

@KingsloPPN | Institute of Psychiatry, Psychology, and Neuroscience | 18.03.2021

Estimate of 10% (95% CI: -77 to 55%) efficacy for AZ vaccine against mild-to-moderate disease from B.1.351 in South Africa. Even the optimistic upper confidence interval of 55% would suggest vaccine-mediated control against this variant very difficult. 1/

The problem (and it could be a very big problem) is countries won’t have solid real-world effectiveness data on protection against severe COVID/hospitalisations for B.1.351 unless variant establishes in populations that have high vaccine coverage. 2/2

@AdamJKucharski | Adam Kucharski | 17.03.2021

La nuova Farmacovigilanza italiana dove le possibili reazioni avverse del vaccino si anticipano in televisione. Come uno spettacolo da non perdere.

@Antonio Addis2 | Antonio Addis | 17.01.2021

“Food As Medicine summit” headed by Dean of Tufts Nutrition School w/ many fake-food giants. I’m sure they will bring ideas about how their new product lines are the medicine you need. Get your ticket and hear how to regain health with Pepsi, Nestle!

@bigfatsurprise | Nina Teicholz | 16.01.2021

Striking data on screening mammography from Cornell colleagues—87% US breast cancer cntrs advise earlier/more screening and do not follow USPSTF/ACS (ie, not specialty society) guidelines. @JAMAInternalMed

@LucMorrisNyc | Luc Morris | 16.03.2021

In effetti dopo un anno di errori di comunicazione a tutti i livelli mediatici e istituzionali, perché sui vaccini avremmo dovuto fare bene?

@paolochiodini | Paolo Chiodini | 15.03.2021

How great is it that our biggest clickbait of the week is Meghan and Harry, and our biggest worry seems to be whether monarchy is doomed rather than whether democracy is doomed or another 100,000 people will die this month?

@Atul_Gawande | Atul Gawande | 15.03.2021

The sequences from the Ebola virus outbreak in Guinea were posted on virological, and they are, to put it mildly, absolutely stunning. The sequences are only 12-13 nucleotides different from those circulating in the 2014-2016 epidemic.

This suggests that this new outbreak resulted from transmission from a persistently infected survivor of the prior epidemic, which is bad for a whole host of reasons, including the further stigmatization of Ebola virus disease survivors.

This is also genuinely shocking to me scientifically. Based on the known mutation rate of EBOV/Makona, we’d expect viruses that have been replicating for 5-7 years, even at low levels, to have many more mutations. Like hundreds. These have 12.

I have no idea how this happens mechanistically and it just goes to show how much we still have to learn about Ebola (and emerging RNA viruses in general). I have so many questions. I hope there will be some epi data that might shed some light on mode of transmission.

And I’m collaborating with @KindrachukJason and some other fantastic colleagues on a project to look at persistence and sexual transmission of Ebola. That couldn’t be a more timely topic.

But as fascinating as this is to me as a virologist who studies Ebola virus, it’s also really troubling as a human being who is well aware of the painful stigmas already faced by many survivors. And the implications for controlling Ebola are extremely worrisome.

To me, this also suggests that we need to step up our efforts to provide Ebola vaccines to people in affected communities, including survivors. Right now Ebola vaccine supplies are limited and are deployed when there’s an outbreak. We need to improve supply and access.

@angie_rasmussen | Angela Rasmussen | 12.03.2021 Thread

Di quest’anno pandemico manca il racconto di chi non ha potuto, o saputo, rispettare distanziamento sociale, zone a colori, smartworking. Di chi non ha potuto smettere di lavorare. Di chi non viaggiava neanche prima. Di chi non ha capito quando bisogna fare un tampone.

@andcapocci | Andrea Capocci | 10.3.2021

The CHA2DS2-VASc Score does NOT accurately predict risk of stroke in patients with Afib Understandable, given that CHA2DS2-VASc is a vascular score w/ no Afib parameters Time for a better risk model for clinic and research?

@ShariqUsman_ | Muhammad Shariq Usman | 9.03.2021

2021 IHC Newsletter, full of updates on the dissemination activities of the @IHC_project in the world: many people’s efforts converging towards the aim of teaching children critical thinking about health claims. Proud that Italy is also part of it.

@camialderighi | Camilla Alderighi | 2.03.2021